Scpharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Scpharmaceuticals

Access the complete profile.

Scpharmaceuticals Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Address	2400 District Avenue Suite 310 Burlington, MA 01803

Note: Revenues for privately held companies are statistical evaluations.


Scpharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Scpharmaceuticals's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Scpharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Scpharmaceuticals Annual Revenue and Growth Rate

Scpharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Scpharmaceuticals's revenues are gauged from an analysis of company filings.

Scpharmaceuticals's Income Statement (based on Industry Averages)

Scpharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Scpharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
January 6, 2017	11	100%	$47 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Scpharmaceuticals is developing and marketing. Scpharmaceuticals doesn't have any recent trademark applications, indicating Scpharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
FUROSCIX Diuretics; pharmaceutical preparations for the treatment of edema, congestive heart failure, cirrhosis, and renal disease	07/12/2016
SC2WEAR Medical devices, namely, control units sold as integral components of drug delivery pumps; and single-use cartridges packaged with medical fluids or solutions sold as integral components of drug delivery pumps	01/08/2016
SCPHARMACEUTICALS Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders	02/11/2013

See all trademarks and details in the Full Report.

Market Share of Scpharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Scpharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Scpharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
LANTHEUS MEDICAL IMAGING	North Billerica, MA	100
LANTHEUS HOLDINGS	North Billerica, MA	38
REPLIMUNE	Woburn, MA	30
SIRTEX MEDICAL	Woburn, MA	19
SCPHARMACEUTICALS	Burlington, MA	14
MAPLIGHT THERAPEUTICS	Burlington, MA	9

Future Competition: Scpharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Scpharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)